Research Article
No access
Published Online: 1 September 2015

Regulation of Granulocyte Colony-Stimulating Factor and Its Receptor in Skeletal Muscle Is Dependent Upon the Type of Inflammatory Stimulus

Publication: Journal of Interferon & Cytokine Research
Volume 35, Issue Number 9

Abstract

The cytokine granulocyte colony-stimulating factor (G-CSF) binds to its receptor (G-CSFR) to stimulate hematopoietic stem cell mobilization, myelopoiesis, and the production and activation of neutrophils. In response to exercise-induced muscle damage, G-CSF is increased in circulation and G-CSFR has recently been identified in skeletal muscle cells. While G-CSF/G-CSFR activation mediates pro- and anti-inflammatory responses, our understanding of the role and regulation in the muscle is limited. The aim of this study was to investigate, in vitro and in vivo, the role and regulation of G-CSF and G-CSFR in skeletal muscle under conditions of muscle inflammation and damage. First, C2C12 myotubes were treated with lipopolysaccharide (LPS) with and without G-CSF to determine if G-CSF modulates the inflammatory response. Second, the regulation of G-CSF and its receptor was measured following eccentric exercise-induced muscle damage and the expression levels we investigated for redox sensitivity by administering the antioxidant N-acetylcysteine (NAC). LPS stimulation of C2C12 myotubes resulted in increases in G-CSF, interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNFα) messenger RNA (mRNA) and an increase in G-CSF, IL-6, and MCP-1 release from C2C12 myotubes. The addition of G-CSF following LPS stimulation of C2C12 myotubes increased IL-6 mRNA and cytokine release into the media, however it did not affect MCP-1 or TNFα. Following eccentric exercise-induced muscle damage in humans, G-CSF levels were either marginally increased in circulation or remain unaltered in skeletal muscle. Similarly, G-CSFR levels remained unchanged in response to damaging exercise and G-CSF/G-CSFR did not change in response to NAC. Collectively, these findings suggest that G-CSF may cooperate with IL-6 and potentially promote muscle regeneration in vitro, whereas in vivo aseptic inflammation induced by exercise did not change G-CSF and G-CSFR responses. These observations suggest that different models of inflammation produce a different G-CSF response.

Get full access to this article

View all available purchase options and get full access to this article.

References

Almekinders LC, Gilbert JA. 1986. Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. Am J Sports Med 14(4):303–308.
Aversa Z, Alamdari N, Hasselgren PO. 2011. Molecules modulating gene transcription during muscle wasting in cancer, sepsis, and other critical illness. Crit Rev Clin Lab Sci 48(2):71–86.
Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T. 2000. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 95(1):270–276.
Bonsignore MR, Morici G, Santoro A, Pagano M, Cascio L, Bonanno A, Abate P, Mirabella F, Profita M, Insalaco G, Gioia M, Vignola AM, Majolino I, Testa U, Hogg JC. 2002. Circulating hematopoietic progenitor cells in runners. J Appl Physiol (1985) 93(5):1691–1697.
Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Van Damme J. 1995. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 86(10):3841–3847.
Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. 2007. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11(2):R49.
Callahan LA, Supinski GS. 2009. Sepsis-induced myopathy. Crit Care Med 37(10 Suppl):S354–S367.
Costa D, Moutinho L, Lima JL, Fernandes E. 2006. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol Pharm Bull 29(8):1659–1670.
de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RH, von dem Borne AE. 1994. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 84(11):3885–3894.
Dinarello CA. 2000. Proinflammatory cytokines. Chest 118(2):503–508.
Duarte RF, Frank DA. 2000. SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways. Blood 96(10):3422–3430.
Evans WJ, Phinney SD, Young VR. 1982. Suction applied to a muscle biopsy maximizes sample size. Med Sci Sports Exerc 14(1):101–102.
Fernandes E, Costa D, Toste SA, Lima JL, Reis S. 2004. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med 37(11):1895–1905.
Frost RA, Nystrom GJ, Lang CH. 2003. Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase. Am J Physiol Regul Integr Comp Physiol 285(5):R1153–R1164.
Gaster M, Beck-Nielsen H, Schroder HD. 2001. Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS 109(11):726–734.
Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A. 1992. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol 149(3):918–924.
Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA. 1989. Increased plasma levels of interleukin-6 in sepsis. Blood 74(5):1704–1710.
Hirose L, Nosaka K, Newton M, Laveder A, Kano M, Peake J, Suzuki K. 2004. Changes in inflammatory mediators following eccentric exercise of the elbow flexors. Exerc Immunol Rev 10:75–90.
Holecek M. 2012. Muscle wasting in animal models of severe illness. Int J Exp Pathol 93(3):157–171.
Kawashima K, Jahan I, Fushimi K, Mihara K, Namba M. 1995. Human fibroblasts (KMST-6/RAS cell line) transformed with 60Co gamma-rays and c-Ha-ras oncogene produce a large amount of granulocyte colony-stimulating factor (G-CSF); production is enhanced by cAMP, theophylline, and butyrate. Cell Struct Funct 20(1):41–45.
Kayacan O, Karnak D, Beder S, Gullu E, Tutkak H, Senler FC, Koksal D. 2006. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. Am J Clin Oncol 29(4):328–335.
Liongue C, Wright C, Russell AP, Ward AC. 2009. Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol 41(12):2372–2375.
Mason S, Wadley GD. 2014. Skeletal muscle reactive oxygen species: a target of good cop/bad cop for exercise and disease. Redox Rep 19(3):97–106.
Mendoza JF, Caceres JR, Santiago E, Mora LM, Sanchez L, Corona TM, Machuca C, Zambrano IR, Martinez RD, Weiss-Steider B. 1990. Evidence that G-CSF is a fibroblast growth factor that induces granulocytes to increase phagocytosis and to present a mature morphology, and that macrophages secrete 45-kd molecules with these activities as well as with G-CSF-like activity. Exp Hematol 18(8):903–910.
Michailidis Y, Karagounis LG, Terzis G, Jamurtas AZ, Spengos K, Tsoukas D, Chatzinikolaou A, Mandalidis D, Stefanetti RJ, Papassotiriou I, Athanasopoulos S, Hawley JA, Russell AP, Fatouros IG. 2013. Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise. Am J Clin Nutr 98(1):233–245.
Mishra DK, Fridén J, Schmitz MC, Lieber RL. 1995. Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg Am 77(10):1510–1519.
Moilanen E. 2014. Two faces of inflammation: an immunopharmacological view. Basic Clin Pharmacol Toxicol 114(1):2–6.
Munoz-Canoves P, Scheele C, Pedersen BK, Serrano AL. 2013. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J 280(17):4131–4148.
Naito T, Goto K, Morioka S, Matsuba Y, Akema T, Sugiura T, Ohira Y, Beppu M, Yoshioka T. 2009. Administration of granulocyte colony-stimulating factor facilitates the regenerative process of injured mice skeletal muscle via the activation of Akt/GSK3alphabeta signals. Eur J Appl Physiol 105(4):643–651.
Nemzek JA, Hugunin KM, Opp MR. 2008. Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp Med 58(2):120–128.
Nielsen AR, Pedersen BK. 2007. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 32(5):833–839.
Nieman DC, Davis JM, Brown VA, Henson DA, Dumke CL, Utter AC, Vinci DM, Downs MF, Smith JC, Carson J, Brown A, McAnulty SR, McAnulty LS. 2004. Influence of carbohydrate ingestion on immune changes after 2 h of intensive resistance training. J Appl Physiol (1985) 96(4):1292–1298.
Obremsky WT, Seaber AV, Ribbeck BM, Garrett WE Jr. 1994. Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am J Sports Med 22(4):558–561.
Opal SM, DePalo VA. 2000. Anti-inflammatory cytokines. Chest 117(4):1162–1172.
Pajkrt D, Manten A, van der Poll T, Tiel-van Buul MM, Jansen J, Wouter ten Cate J, van Deventer SJ. 1997. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 90(4):1415–1424.
Pauksen K, Elfman L, Ulfgren AK, Venge P. 1994. Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 88(2):256–260.
Paulsen G, Benestad HB, Strøm-Gundersen I, Mørkrid L, Lappegård KT, Raastad T. 2005. Delayed leukocytosis and cytokine response to high-force eccentric exercise. Med Sci Sports Exerc 37(11):1877–1883.
Pedersen BK. 2007. IL-6 signalling in exercise and disease. Biochem Soc Trans 35 (Pt 5):1295–1297.
Pedersen BK. 2011. Muscles and their myokines. J Exp Biol 214 (Pt 2):337–346.
Pedersen BK, Akerström TCA, Nielsen AR, Fischer CP. 2007. Role of myokines in exercise and metabolism. J Appl Physiol(1985) 103(3):1093–1098.
Pedersen BK, Febbraio MA. 2008. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88(4):1379–1406.
Pedersen BK, Fischer CP. 2007. Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care 10(3):265–271.
Petersen AM, Pedersen BK. 2005. The anti-inflammatory effect of exercise. J Appl Physiol 98(4):1154–1162.
Peterson JM, Pizza FX. 2009. Cytokines derived from cultured skeletal muscle cells after mechanical strain promote neutrophil chemotaxis in vitro. J Appl Physiol (1985) 106(1):130–137.
Petridou A, Chatzinikolaou A, Fatouros I, Mastorakos G, Mitrakou A, Chandrinou H, Papassotiriou I, Mougios V. 2007. Resistance exercise does not affect the serum concentrations of cell adhesion molecules. Br J Sports Med 41(2):76–79; discussion 79.
Philippou A, Maridaki M, Theos A, Koutsilieris M. 2012. Cytokines in muscle damage. Adv Clin Chem 58:49–87.
Powers SK, Duarte J, Kavazis AN, Talbert EE. 2010. Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp Physiol 95(1):1–9.
Purpora R, Massad W, Ferrari G, Reynoso E, Criado S, Miskoski S, Pajares A, Garcia NA. 2013. The NSAIDs Indomethacin and Diflunisal as scavengers of photogenerated reactive oxygen species. Photochem Photobiol 89(6):1463–1470.
Raastad T, Owe SG, Paulsen G, Enns D, Overgaard K, Crameri R, Kiil S, Belcastro A, Bergersen L, Hallen J. 2010. Changes in calpain activity, muscle structure, and function after eccentric exercise. Med Sci Sports Exerc 42(1):86–95.
Roberts AW. 2005. G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors 23(1):33–41.
Schoenfeld BJ. 2012a. Does exercise-induced muscle damage play a role in skeletal muscle hypertrophy? J Strength Cond Res 26(5):1441–1453.
Schoenfeld BJ. 2012b. The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development. Sports Med 42(12):1017–1028.
Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. 2008. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7(1):33–44.
Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. 2003. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 17(8):884–886.
Stratos I, Rotter R, Eipel C, Mittlmeier T, Vollmar B. 2007. Granulocyte-colony stimulating factor enhances muscle proliferation and strength following skeletal muscle injury in rats. J Appl Physiol (1985) 103(5):1857–1863.
Stupka N, Tarnopolsky MA, Yardley NJ, Phillips SM. 2001. Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol (1985) 91(4):1669–1678.
Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. 2002. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 8:6–48.
Suzuki K, Peake J, Nosaka K, Okutsu M, Abbiss CR, Surriano R, Bishop D, Quod MJ, Lee H, Martin DT, Laursen PB. 2006. Changes in markers of muscle damage, inflammation and HSP70 after an Ironman Triathlon race. Eur J Appl Physiol 98(6):525–534.
Tura O, Crawford J, Barclay GR, Samuel K, Hadoke PW, Roddie H, Davies J, Turner ML. 2010. Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. J Thromb Haemost 8(7):1614–1623.
Uraz S, Tahan G, Aytekin H, Tahan V. 2013. N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scand J Clin Lab Invest 73(1):61–66.
Utsumi T, Klostergaard J, Akimaru K, Edashige K, Sato EF, Utsumi K. 1992. Modulation of TNF-alpha-priming and stimulation-dependent superoxide generation in human neutrophils by protein kinase inhibitors. Arch Biochem Biophys 294(1):271–278.
Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, Kamachi S. 1989. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73(1):117–122.
Weiss M, Fischer G, Barth E, Boneberg E, Schneider EM, Georgieff M, Hartung T. 2001. Dissociation of LPS-induced monocytic ex vivo production of granulocyte colony-stimulating factor (G-CSF) and TNF-alpha in patients with septic shock. Cytokine 13(1):51–54.
Wright CR, Brown EL, Della Gatta PA, Ward AC, Lynch GS, Russell AP. 2014. G-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle. Front Physiol 5:175.
Yamada M, Suzuki K, Kudo S, Totsuka M, Nakaji S, Sugawara K. 2002. Raised plasma G-CSF and IL-6 after exercise may play a role in neutrophil mobilization into the circulation. J Appl Physiol (1985) 92(5):1789–1794.
Yan B, Wei JJ, Yuan Y, Sun R, Li D, Luo J, Liao SJ, Zhou YH, Shu Y, Wang Q, Zhang GM, Feng ZH. 2013. IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation. J Immunol 190(11):5882–5893.
Yuan X, Cong Y, Hao J, Shan Y, Zhao Z, Wang S, Chen J. 2004. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. J Mol Biol 339(1):131–144.
Zhu QS, Xia L, Mills GB, Lowell CA, Touw IP, Corey SJ. 2006. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood 107(5):1847–1856.

Information & Authors

Information

Published In

cover image Journal of Interferon & Cytokine Research
Journal of Interferon & Cytokine Research
Volume 35Issue Number 9September 2015
Pages: 710 - 719
PubMed: 26057332

History

Published in print: September 2015
Published online: 1 September 2015
Published ahead of print: 9 June 2015
Accepted: 27 March 2015
Received: 11 September 2014

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Craig Robert Wright
Centre for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Victoria, Australia.
Erin Louise Brown
Centre for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Victoria, Australia.
Paul A. Della Gatta
Centre for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Victoria, Australia.
Ioannis G. Fatouros
Department of Physical Education and Sport Sciences, Democritus University of Thrace, Komotini, Greece.
The Institute of Human Performance and Rehabilitation, Center for Research and Technology–Thessaly, Trikala, Greece.
Leonidas G. Karagounis
Nestlé Research Center, Nestec Ltd., Lausanne, Switzerland.
School of Physical Education and Sport Sciences, University of Thessaly, Karies, Trikala, Greece.
Gerasimos Terzis
Athletics Laboratory, School of Physical Education and Sports Science, University of Athens, Athens, Greece.
Georgios Mastorakos
Endocrine Unit, Second Department of Obstetrics and Gynecology, Athens University Medical School, Athens, Greece.
Yannis Michailidis
Department of Physical Education and Sport Sciences, Democritus University of Thrace, Komotini, Greece.
Dimitris Mandalidis
Athletics Laboratory, School of Physical Education and Sports Science, University of Athens, Athens, Greece.
Kontantinos Spengos
The 1st Department of Neurology, University of Athens, School of Medicine, Eginition Hospital, Athens, Greece.
Athanasios Chatzinikolaou
Department of Physical Education and Sport Sciences, Democritus University of Thrace, Komotini, Greece.
Spiros Methenitis
Athletics Laboratory, School of Physical Education and Sports Science, University of Athens, Athens, Greece.
Dimitrios Draganidis
Department of Physical Education and Sport Sciences, Democritus University of Thrace, Komotini, Greece.
Athanasios Z. Jamurtas
The Institute of Human Performance and Rehabilitation, Center for Research and Technology–Thessaly, Trikala, Greece.
School of Physical Education and Sport Sciences, University of Thessaly, Karies, Trikala, Greece.
Aaron Paul Russell
Centre for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Victoria, Australia.

Notes

Address correspondence to:Prof. Aaron Paul RussellCentre for Physical Activity and NutritionSchool of Exercise and Nutrition SciencesDeakin UniversityBurwood, Vic 3125Australia
E-mail: [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Topics

Back to Top